Profile data is unavailable for this security.
About the company
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
- Revenue in USD (TTM)1.84bn
- Net income in USD200.97m
- Incorporated1970
- Employees15.71k
- LocationChemed Corp255 E 5th St Ste 2600CINCINNATI 45202-4138United StatesUSA
- Phone+1 (513) 762-6690
- Fax+1 (302) 655-5049
- Websitehttp://www.chemed.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LHC Group, Inc. | 2.04bn | 85.64m | 3.67bn | 14.60k | 42.40 | 2.65 | 30.38 | 1.80 | 2.75 | 2.75 | 65.38 | 44.05 | 1.04 | -- | 7.36 | 139,561.00 | 5.30 | 6.64 | 6.39 | 8.04 | 36.51 | 37.90 | 5.09 | 4.54 | -- | 15.99 | 0.1358 | 0.00 | 70.33 | 22.42 | 76.05 | 23.26 | -1.32 | -- |
| Amedisys Inc | 1.81bn | 123.88m | 4.35bn | 21.00k | 35.87 | 7.74 | 31.20 | 2.40 | 3.77 | 3.77 | 55.16 | 17.48 | 1.85 | -- | 8.29 | 86,287.48 | 12.75 | 6.10 | 17.47 | 8.44 | 40.51 | 41.40 | 6.89 | 3.12 | -- | 52.80 | 0.3275 | 0.00 | 10.01 | 5.88 | 130.84 | -- | -30.94 | -- |
| Encompass Health Corp | 4.42bn | 309.30m | 6.59bn | 30.06k | 21.41 | 5.16 | 10.93 | 1.49 | 3.12 | 3.13 | 44.33 | 12.93 | 0.8114 | -- | 9.29 | 147,125.80 | 7.21 | 7.36 | 9.31 | 9.01 | 96.35 | 96.03 | 8.89 | 9.08 | -- | 5.02 | 0.5875 | 34.85 | 9.28 | 13.74 | 7.61 | 4.95 | 4.55 | 23.64 |
| Chemed Corporation | 1.84bn | 200.97m | 6.65bn | 15.71k | 34.53 | 10.69 | 27.55 | 3.62 | 12.09 | 12.09 | 110.57 | 39.05 | 1.82 | 210.10 | 14.39 | 116,971.90 | 19.88 | 13.80 | 24.63 | 17.75 | 31.20 | 30.02 | 10.94 | 7.65 | 0.7772 | 45.34 | 0.1398 | 13.41 | 6.96 | 4.75 | 128.71 | 21.63 | 12.51 | 8.83 |
| Molina Healthcare, Inc. | 17.67bn | 792.00m | 7.71bn | 11.00k | 10.33 | 4.46 | 8.63 | 0.4362 | 11.90 | 11.90 | 265.46 | 27.56 | 2.29 | -- | 14.81 | 1,606,636.00 | 10.25 | 1.58 | 25.36 | 3.86 | 17.80 | 14.74 | 4.48 | 0.6301 | -- | 10.50 | 0.4709 | 0.00 | -4.99 | 23.45 | 254.37 | 73.61 | -21.09 | -- |
| Davita Inc | 11.25bn | 547.52m | 9.41bn | 77.70k | 17.85 | 2.38 | 7.07 | 0.836 | 3.29 | 0.8123 | 67.56 | 24.62 | 0.5718 | 76.48 | 5.84 | 144,842.60 | 3.71 | 4.45 | 5.56 | 5.65 | 28.80 | 29.14 | 6.48 | 6.88 | 1.10 | 2.87 | 0.623 | 0.00 | 4.86 | -0.6183 | -6.17 | -0.1217 | 9.83 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2019 | 1.92m | 12.07% |
| BlackRock Fund Advisorsas of 30 Jun 2019 | 1.54m | 9.68% |
| Neuberger Berman Investment Advisers LLCas of 30 Jun 2019 | 700.93k | 4.40% |
| Acadian Asset Management LLCas of 30 Jun 2019 | 519.10k | 3.26% |
| SSgA Funds Management, Inc.as of 30 Jun 2019 | 419.98k | 2.64% |
| Riverbridge Partners LLCas of 30 Sep 2019 | 372.75k | 2.34% |
| Fisher Asset Management LLCas of 30 Jun 2019 | 348.96k | 2.19% |
| Fidelity Management & Research Co.as of 30 Jun 2019 | 309.03k | 1.94% |
| Columbia Wanger Asset Management LLCas of 30 Jun 2019 | 271.70k | 1.71% |
| Investec Asset Management Ltd.as of 30 Jun 2019 | 269.95k | 1.70% |
